Blog

Bypassing Immune Rejection in Stem-Cell-Based Therapies – PR Web (press release)

Bypassing Immune Rejection in StemCell-Based Therapies
PR Web (press release)
In a recent study published by STEM CELLS, a research group from Stanford University describes a novel regimen for quashing the immunologic barrier with a short-course treatment of two costimlation-adhesion blockade agents, to allow engraftment of
New Stem Cell Treatment Programs at Eterna MDVirtual-Strategy Magazine (press release)


Injections of stem cells could prevent heart attacksScotsman
How skin is maintained throughout life<font …read more    

2013-08-16 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.